Latest Regulatory Approvals News

The Foreign Investment Review Board has extended its deadline to assess Caterpillar’s proposed acquisition of RPMGlobal, pushing the decision to 23 January 2026. This procedural extension keeps the deal on track but leaves some questions open for shareholders.

McLaren Minerals’ Pre-Feasibility Study confirms a robust, low-risk titanium mining project in Western Australia, projecting nearly A$900 million EBITDA over 16 years. The study highlights strong market demand and validated processing methods, setting the stage for the next development phase.

Horizon Oil has approved a strategic $1.5 million investment to install a booster compressor at its Nam Phong gas field in Thailand, aiming to increase production by at least 40% by mid-2026.

Tetratherix has successfully completed the second safety review of its TetraDerm clinical trial's second cohort, showing no adverse events and confirming a strong safety profile. The trial now progresses to its final phase, targeting a growing reconstructive surgery market.

Miramar Resources is set to launch a multi-commodity drilling campaign in early 2026, focusing on gold targets near Kalgoorlie and high-grade copper-lead-silver mineralisation in the Gascoyne region.

Lunnon Metals reports standout drilling results at Lady Herial, revealing thick, high-grade gold mineralisation beyond current open pit plans and setting the stage for expanded mining activity.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its Vision-MR Diagnostic Catheter, paving the way for commercial sales in the US electrophysiology market.

Haranga Resources has confirmed a significant continuous gold mineralised trend exceeding 800 metres at its Ibel South Gold Project in Senegal, with plans for deeper drilling in early 2026 to explore high-grade zones and untested anomalies.

Lunnon Metals has reported significant gold intercepts at its Paringa West prospect, confirming a promising new geological structure within the prolific St Ives gold camp. The results bolster the company’s exploration ambitions in Western Australia’s renowned Foster-Baker Project.